Dr. Anna Gasparyan, MD

Dr. Gasparyan practices at Desert Vascular Associates in Palm Desert, California.

Dr. Gasparyan's NPI, 1598055923, was assigned on April 19, 2011. Dr. Gasparyan graduated from St. George's University School of Medicine in 2006. Dr. Gasparyan holds California license A111683.

Dr. Gasparyan's primary practice is Desert Vascular Associates, at 74000 Country Club Dr, Palm Desert, CA 92260 in Riverside County. The practice phone is (917) 597-4083.

Dr. Gasparyan's primary practice is Desert Vascular Associates in Palm Desert, California. Dr. Gasparyan is also affiliated with Eisenhower Health. The medical group on file is Eisenhower Health. Dmand AI also links Dr. Gasparyan to 2 more hospitals, 2 home health agencies, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gasparyan practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Gasparyan's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Gasparyan is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Gasparyan's licenses on file in 3 states: California, Pennsylvania and New Jersey.

Dmand AI lists amputation, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery, leg revascularization and peripheral vascular disease among the conditions Dr. Gasparyan treats.

CMS data shows 2,544 Medicare services from Dr. Gasparyan across 22 procedure codes in 2024, for 600 Medicare patients. Medicare paid $369,178 for them.

CMS counts 600 Medicare patients who saw Dr. Gasparyan in 2024. The largest group is 75 to 84, with 233 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gasparyan's median patient age at 66, with 56% women.

In 2024, Dr. Gasparyan wrote 226 Medicare Part D claims for 101 patients. 92% of them were for generic drugs. CMS names the drug for 184 of them, across 4 drugs with 11 or more claims each, at $6,067 in total drug cost. In 2023, CMS named 304 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Gasparyan for performance year 2024, reported individually. Dr. Gasparyan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gasparyan as offering telehealth. CMS counts 594 procedures of removal of tissue by Dr. Gasparyan, more than 97% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Gasparyan, published from 2009 to 2012. Dr. Gasparyan's most frequent co-author is Elizabeth Cirincione, MD.

CMS Open Payments shows 83 general payments to Dr. Gasparyan from 30 drug and device companies from 2016 to 2025. Device or supply loans make up the largest share, 74% of the total. AngioDynamics, Inc. paid the most, $13,119.

Dmand AI lists 4 awards for Dr. Gasparyan, most recently NUMC’S ANNA GASPARYAN, MD, CHIEF RESIDENT OF GENERAL SURGERY, AWARDED FIRST PLACE IN THE NASSAU SURGICAL SOCIETY’S AMERICAN COLLEGE OF SURGEONS DAY in 2011. Dr. Gasparyan serves on JFK Medical executive committee.

Dr. Gasparyan graduated from St. George's University School of Medicine in 2006. Dr. Gasparyan is a member of ACS and SVS.

Dr. Gasparyan is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.